Biosim

Biosim AI strives to significantly reduce the time for small-molecule drug discovery from years to months with the help of advanced computational methods and artificial intelligence. The company is based in the Boston area and was founded in 2020 by Garegin Papoian, an expert in Theoretical and Computational Chemistry and Biophysics and current Biosim AI CEO.

Jobs: